Ultrahigh-Throughput Single Emulsion Droplet Screening for the Discovery of New B Antigen Cleaving Enzymes
In search of efficient α-galactosidases that can convert B red blood cells (RBCs) to universal type RBCs, we have developed a simple and robust system for ultrahigh-throughput droplet-based microfluidic screening. Here, a multienzyme coupled assay with a fluorogenic B antigen tetrasaccharide substrate is encapsulated within single emulsion water-in-oil droplets alongside single cells from metagenomic libraries. The resulting fluorescent droplets containing candidate B antigen cleaving enzymes are sorted using a commercially available, walk-up droplet sorting instrument before validation, cloning, and characterization of the hits. Using this approach, we identified and characterized an α-1,3-galactosidase (PvGH110) from the human gut microbiome capable of converting B-to-O-type RBCs. The simplicity, efficiency, and accessibility of our microfluidic-based system make it suitable for nonspecialist laboratories and offer a promising tool to discover enzymes that enable the generation of a universal O blood type.
Authors
- Jayachandran N. Kizhakkedathu (ORCID: https://orcid.org/0000-0001-7688-7574)
- D. Seale
- Peter Rahfeld
- Haisle Moon (ORCID: https://orcid.org/0000-0001-6030-6851)
- Seyed A. Nasseri (ORCID: https://orcid.org/0000-0002-8380-7701)
- Jacob F. Wardman (ORCID: https://orcid.org/0000-0002-8235-3576)
- Stephen G. Withers (ORCID: https://orcid.org/0000-0002-6722-5701)
- Charlotte Olagnon (ORCID: https://orcid.org/0000-0002-1485-5865)
- Feng Liu (ORCID: https://orcid.org/0000-0002-4442-7028)
- Hongming Chen (ORCID: https://orcid.org/0000-0003-1231-7331)
- Steven Hallam (ORCID: https://orcid.org/0000-0002-4889-6876)
Institutions
- University of British Columbia (CA)
- Genome British Columbia (CA)
Publication Details
- Journal
- ACS Catalysis
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1021/acscatal.4c02165
- Citations
- 4
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- Canadian Blood Services
- Canada Foundation for Innovation
- Austrian Science Fund
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
- Canadian Glycomics Network